lucentis
Showing 1 - 25 of 27
Neovascular (Wet) Age-related Macular Degeneration Trial (BAT5906 injection, Lucentis)
Not yet recruiting
- Neovascular (Wet) Age-related Macular Degeneration
- BAT5906 injection
- Lucentis
- (no location specified)
Jun 26, 2022
Age-Related Macular Degeneration Trial in Philippines, United States (2.0 mg DE-122 Injectable Solution + Lucentis, 4.0 mg
Completed
- Age-Related Macular Degeneration
- 2.0 mg DE-122 Injectable Solution + Lucentis
- +2 more
-
Gilbert, Arizona
- +13 more
Jun 22, 2021
Wet Age-related Macular Degeneration Trial in Chengdu (MW02, Lucentis)
Recruiting
- Wet Age-related Macular Degeneration
- MW02
- Lucentis
-
Chengdu, Si Chuan, ChinaWest China Hospital of Sichuan University
Mar 17, 2022
Wet Age-related Macular Degeneration Trial in Hungary, Latvia, United States (Zimura, Lucentis)
Completed
- Wet Age-related Macular Degeneration
- Zimura
- Lucentis
-
Phoenix, Arizona
- +27 more
Feb 3, 2022
Nonproliferative Diabetic Retinopathy Trial (Lucentis)
Completed
- Nonproliferative Diabetic Retinopathy
- Lucentis
- (no location specified)
May 8, 2020
Patterns With Lucentis® in Real-life Conditions in All Approved
Completed
- Neovascular (Wet) Age-related Macular Degeneration
- Lucentis
-
Ettlingen, Baden Wuerttemberg, Germany
- +174 more
Apr 12, 2021
Diabetic Macular Edema, Cataract Trial in Shanghai (Lucentis)
Unknown status
- Diabetic Macular Edema
- Cataract
- Lucentis
-
Shanghai, Shanghai, ChinaChanghai Hospital
Mar 25, 2020
Age Related Macular Degeneration Trial in China (HLX04-O,recombinant anti-vascular endothelial growth factor (VEGF) humanized
Recruiting
- Age Related Macular Degeneration
- HLX04-O,recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection
- Lucentis
-
Bengbu, Anhui, China
- +40 more
Apr 27, 2022
Age Related Macular Degeneration Trial in Lyon (Avastin, Lucentis)
Completed
- Age Related Macular Degeneration
- Avastin
- Lucentis
-
Lyon, FranceService d'Ophtalmologie - Hôpital de la Croix Rousse
May 23, 2019
Wet Age-related Macular Degeneration Trial in Shanghai (lucentis, QL1205)
Completed
- Wet Age-related Macular Degeneration
- lucentis
- QL1205
-
Shanghai, Shanghai, ChinaShanghai General Hospital, Shanghai Jiao Tong University School
Apr 10, 2019
Proliferative Diabetic Retinopathy Patients
Unknown status
- Proliferative Diabetic Retinopathy
- Panretinal Photocoagulation
- Lucentis
-
Baltimore, MarylandElman Retina Group
Feb 6, 2019
Wet Macular Degeneration Trial in Seoul (Lucentis)
Completed
- Wet Macular Degeneration
- Lucentis
-
Seoul, Korea, Republic ofSeoul National University Hospital
Apr 17, 2018
Assessment of Color Vision in Diabetic Patients
Completed
- Retinopathy, Diabetic
- lucentis
-
Goiânia, Goias, BrazilInstituto de Olhos de Goiania
Nov 16, 2017
Age-Related Macular Degeneration Trial in West Columbia (E10030 plus Lucentis, Lucentis)
Completed
- Age-Related Macular Degeneration
- E10030 plus Lucentis
- Lucentis
-
West Columbia, South CarolinaPalmetto Retinal Center
Apr 6, 2017
Age Related Macular Degeneration (AMD) Trial in Remuera, Auckland (Lucentis, PF582)
Completed
- Age Related Macular Degeneration (AMD)
- Lucentis
- PF582
-
Remuera, Auckland, New Zealand
- +1 more
May 9, 2016
Diabetic Macular Edema Trial in Vienna (Bevacizumab (Avastin), Triamcinolone, Sham)
Completed
- Diabetic Macular Edema
- Bevacizumab (Avastin)
- +3 more
-
Vienna, AustriaDept. of Ophthalmology, Medical University of Vienna
Mar 3, 2016
Age-Related Macular Degeneration (AMD) Trial in United States (PAN-90806 Ophthalmic Solution, Lucentis)
Completed
- Age-Related Macular Degeneration (AMD)
- PAN-90806 Ophthalmic Solution
- Lucentis
-
Colorado Springs, Colorado
- +21 more
Sep 27, 2016
Study Evaluating Genotypes Using Lucentis
Terminated
- Age-Related Maculopathy
- Lucentis
-
Santa Barbara, California
- +2 more
Feb 10, 2015
Exudative Macular Degeneration, Diabetic Macular Edema Trial in Grand Rapids (Avastin, Lucentis)
Completed
- Exudative Macular Degeneration
- Diabetic Macular Edema
- Avastin
- Lucentis
-
Grand Rapids, MichiganVitreo-Retinal Associates
Dec 16, 2014
Retinal Pigment Epithelial Detachment With Vascularization, Age Related Macular Degeneration Trial in Milano (Iray, Lucentis)
Unknown status
- Retinal Pigment Epithelial Detachment With Vascularization
- Age Related Macular Degeneration
- Iray
- Lucentis
-
Milano, ItalyUniversità Vita-Salute Istituto Scientifico San Raffaele
Oct 24, 2012
Investigates Improvement in Vision Following Switching From
Completed
- Wet AMD
- Lucentis
-
Honolulu, HawaiiRetina Institute of Hawaii
May 24, 2012
Retinal Vein Occlusion Trial in Vienna (Lucentis)
Completed
- Retinal Vein Occlusion
- Lucentis
-
Vienna, AustriaVienna General Hospital
Dec 7, 2009